National Hog Farmer is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Virox conducts efficacy tests on disinfectants against ASF

Virox conducts efficacy tests on disinfectants against ASF

The tests were conducted in accordance with the EN 14675 test method, a protocol specific for testing the virucidal efficacy of chemical disinfectants for use in the veterinary field.

Virox Technologies, the creators of the patented technology Accelerated Hydrogen Peroxide, recently conducted an independent efficacy test on two of its disinfectants against the African swine fever virus. AHP is found in Virox Animal Health's Intervention farm disinfectant, known as Intervención in Mexico, and Prevail disinfectants in Canada.

The efficacy testing for both AHP disinfectants was undertaken by the European Reference Laboratory for African Swine Fever in Madrid, Spain. The tests were conducted in accordance with the EN 14675 test method, a protocol specific for testing the virucidal efficacy of chemical disinfectants for use in the veterinary field. According the company announcement, both disinfectants achieved complete inactivation of the ASF virus (>5.5 log of virus titer) at the respective recommended dilution rates of 1:64 and 1:40 with a 5 minute contact time. The test method employed included the presence of high-level soiling, hard water and was conducted at room temperature (20˚C, 68˚F), in order to assess both disinfectants' performance and suitability for use in real world “on-farm” conditions.

“Our AHP technology has been proven to be highly virucidal against both enveloped and non-enveloped viruses. We were confident both Intervention and Prevail would be effective against ASF, but having direct confirmation gives us and our customer’s reassurance,” says José A. Ramirez, executive vice president and lead science advisor at Virox Technologies. “Until now, the veterinary community has relied on generic chemicals utilized under unrealistic conditions of concentration and contact time for environmental decontamination from ASF. Even the small number of formulated products that have demonstrated efficacy against the virus through direct data are difficult to handle and suffer from less-than ideal occupational safety and environmental profiles. This study effectively enables a better solution, from the points of ease of use and application, toxicity to animals and workers, as well as lower impact on the environment and materials.”

The firm says effective disinfection needs to also include ancillary activities such as cleaning prior to disinfection, proper product reconstitution/dilution, proper application and reasonable validation of acceptable decontamination.

Source: Virox Technologies, who are solely responsible for the information provided, and wholly own the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish